Sukhtian Faisal Ghiath bought OTLK

May 27, 2026 · Form 4 insider transaction

Sukhtian Faisal Ghiath bought 122,174 shares of Outlook Therapeutics, Inc. at $0.41 per share, a transaction worth $50.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.